Forte Biosciences, Inc.

This Phase 1 trial tests the safety and tolerability of a new drug called FB102 in 56 healthy volunteers. Participants receive either a single dose, multiple weekly doses, or a placebo. The study focuses on side effects and how the drug moves through the body, not on treating any…